These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7527175)

  • 1. Peripheral blood progenitor cell transplantation estimated by three-colour (CD34, HLA-DR, CD33) flow cytometry.
    Urashima M; Ohkawara J; Hoshi Y; Kato Y; Uchiyama H; Kamijo M; Akatsuka J; Maekawa K
    Acta Haematol; 1994; 92(1):23-8. PubMed ID: 7527175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.
    Dercksen MW; Rodenhuis S; Dirkson MK; Schaasberg WP; Baars JW; van der Wall E; Slaper-Cortenbach IC; Pinedo HM; Von dem Borne AE; van der Schoot CE
    J Clin Oncol; 1995 Aug; 13(8):1922-32. PubMed ID: 7543561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD34+ cord blood cells and their subpopulations in preterm and term neonates using three-color flow cytometry.
    Meister B; Tötsch M; Mayr A; Widschwendter M; Huter O; Sperl W
    Biol Neonate; 1994; 66(5):272-9. PubMed ID: 7533008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diversity of human hematopoietic stem/progenitor cells. I. Two-color flow cytometric analysis of the different functional subpopulations of CD 34+ hematopoietic stem/progenitor cells riched from human bone marrow].
    Xi YZ; Zhang SX; Tang PH; Wei W; Kong FH
    Shi Yan Sheng Wu Xue Bao; 1996 Mar; 29(1):49-57. PubMed ID: 9208642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K; Higgins N; Akard L; Chang Q; Jansen J; Thompson J; Dugan M; Rizzo MT; English D
    J Hematother; 1997 Jun; 6(3):243-52. PubMed ID: 9234179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L; Leemhuis T; Srour EF; Yang YC
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified quantitation of myeloid dendritic cells in peripheral blood using flow cytometry.
    Upham JW; Lundahl J; Liang H; Denburg JA; O'Byrne PM; Snider DP
    Cytometry; 2000 May; 40(1):50-9. PubMed ID: 10754517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.
    Pecora AL; Preti RA; Gleim GW; Jennis A; Zahos K; Cantwell S; Doria L; Isaacs R; Gillio AP; Michelis MA; Brochstein JA
    J Clin Oncol; 1998 Jun; 16(6):2093-104. PubMed ID: 9626209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Katsura K; Yamaguchi K; Fukuhara S
    Vox Sang; 2000; 78(2):106-12. PubMed ID: 10765146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
    Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
    Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation.
    Bender JG; Williams SF; Myers S; Nottleman D; Lee WJ; Unverzagt KL; Walker D; To LB; Van Epps DE
    Bone Marrow Transplant; 1992 Sep; 10(3):281-5. PubMed ID: 1384900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.